Upcoming Webinars

Advancing Conjugated Therapeutics: From ADC Innovation to Integrated Bioanalysis Strategies

June 16, 2026

Conjugated therapeutics, including antibody-drug conjugates (ADCs) and antibody-oligonucleotide conjugates (AOCs), are reshaping the future of targeted therapies and creating new opportunities across oncology, immunotherapy, and precision medicine. As the field continues to evolve, next-generation development strategies are increasingly focused on enhancing efficacy, overcoming drug resistance, and achieving meaningful differentiation through discovery, screening, and pharmacological evaluation approaches. On June 16th, join us for an exclusive webinar in which our experts will share perspectives on ADC discovery, preclinical pharmacology, clinical bioanalysis, and DMPK strategies for AOCs.

Register Now